Completed / Not Recruiting
The RNS® System Nautilus Study
The NeuroPace RNS® System Nautilus Study evaluated responsive thalamic stimulation for idiopathic generalized epilepsy. Enrollment has ended and the study is no longer recruiting.
Clinical Trials
Clinical studies in neurotechnology, gene therapy, and cellular therapy.
HuNeu participates in translational clinical studies that bring emerging neuroscience, neuromodulation, and cellular therapies closer to patient care.
Results Pending
NTE001 Neurona Stem Cell Trial for Temporal Lobe Epilepsy
The NTE001 study is a Phase I/II clinical trial evaluating NRTX-1001, an investigational nerve cell therapy, for drug-resistant unilateral mesial temporal lobe epilepsy. Results are pending.
Learn more about NTE001Coming Soon
More studies are in development.
Additional clinical trials and translational research opportunities will be listed here as they become available.